IRISH PHARMACY JOURNAL Official Journal of the Pharmaceutical Society of Ireland

Index - Volume 85 January to December, 2007

Compiled by Carol Keogh

The Pharmaceutical Society of Ireland, 18 Shrewsbury Road, Ballsbridge, Dublin 4, Republic of Ireland IRISH PHARMACY JOURNAL

INDEX TO VOLUME 85 Page numbers Issue

1 – 40 January ‘07 R eaders should note that signed articles are indexed under two entries – the name of the contributor and the 41- 84 February ‘07 subject of the article. All references to “Society” refer to the Pharmaceutical Society of Ireland. All references to 85 - 128 March ‘07 “Council” refer to the Council of the Pharmaceutical Society of Ireland. Cross-references are listed in soft brackets 129 - 180 April ‘07 following each entry. Hard brackets indicate parentheses in a title. 181 - 220 May ‘07 ABBREVIATIONS : The following abbreviations are used in the index: 221 - 264 June ‘07 265 - 328 July ‘07 ADR Adverse Drug Reactions MHRA Medicines and Healthcare Regulatory Agency (UK) ADVANCE Action in Diabetes and Vascular Disease: perindopril/ MMR Measles, Mumps and Rubella 329 - 376 Aug/Sept ‘07 indapamide and Diamicron MR Controlled Evacuation MRII Medical Representatives’ Institute of Ireland 377 - 416 October ‘07 AED Automated External Defibrillator MRSA methicillin -resistant Staphylococcus aureus 417 - 460 November ‘07 AGM Annual General Meeting NAPHT National Association of Hospital Pharmacy Technicians CHMP Committee for Human Medicinal Products NCPE National Centre for Pharmacoeconomics 461 - 500 Dec ‘07/Jan ‘08 COPD Chronic Obstructive Pulmonary Disease NHS National Health Service DIT Dublin Institute of Technology OAB Overactive bladder EC European Commission OHLSC Our Lady’s Hospital for Sick Children EMCDDA European Monitoring Centre for Drugs & Drug Addiction OTC Office of Tobacco Control EMEA European Medicines Agency OTC Over the Counter EU European Union PCDS Primary Care Dermatology Society FDA Food & Drug Administration (US) PREVAIL Prevention of VTE after Acute Ischaemic Stroke with FIP Federation Internationale des Pharmaceutiques LMWH Enoxaparin FSAI Food Safety Authority of Ireland RA Rheumatoid Arthritis HIQA Health Information and Quality Authority PSI Pharmaceutical Society of Ireland HPAI Hospital Pharmacists’ Association of Ireland R&D Research and Development HSE Health Service Executive RCSI Royal College of Surgeons in Ireland HSP Health Support Programme RFID Radio Frequency Identification IHF Irish Heart Foundation RPSGB Royal Pharmaceutical Society of Great Britain IMB Irish Medicines Board SOPs Standard Operating Procedures IPA Irish Patients’ Association TB Tuberculosis IPHA Irish Pharmaceutical Healthcare Association TCD Trinity College Dublin PMII Pharmaceutical Managers’ Institute of Ireland TCM Traditional Chinese Medicine POM Prescription-only medicine UCC University College Cork MCQs Multiple Choice Questions UK United Kingdom

A Arthritis Betaferon® Orencia® (abatacept) - treatment for RA Biopharmaceuticals – the new weapon of choice Adalimumab (Orencia) 371 in the battle against disease CHMP give Humira® (adalimumab) positive Aseptic Compounding (Collins, R.) 166-169 opinion for the treatment of Crohn’s Disease Designing a capacity plan for the Aseptic The Science behind Biopharmaceuticals (CHMP/Crohn’s Disease) 238 Compounding Unit in St. James’s Hospital (Cryan, S.A./Moran, P.J.) 202-204 Addiction (Capacity Planning/Hospital Pharmacy Issue/ Blood Pressure Suboxone® (buprenorphine/naloxone) – a new O’Boyle, N./St. James’s Hospital) 303-306 Impact of a community pharmacy-directed weight alternative to methadone (Buprenorphine/ Astellas European Foundation support TCD management programme on blood pressure Methadone) 124 School of Pharmacy research (R&D/ findings (Obesity/O’Brien, C./ Young Scientist Project [2007] – Codeine Schools) 102 Weight Management) 240-246 Addiction in Ireland (Codeine) 102 Asthma Trial shows benefits of blood pressure lowering ADR (see also Adverse Drug Reactions) Facts about asthma in Ireland 286 treatment for over-80s (Clinical Trial) 494 IMB launches new website with online ADR Singulair now available for children aged 2-14 Blood Tests reporting (IMB) 432 years with mild persistent Asthma Reflotron Plus – on the spot blood test results ADVANCE study shows benefits of perindopril/ (Paediatrics/Singulair) 36, 81 (Point of Care/Reflotron Plus) 321 indapamide (Perindopril) 454 Audit Committee Bonviva® studies show significant benefit in Adverse Drug Reactions and the role of the Fostering the principles of good governance reducing risk of non-vertebral fractures Pharmacist – Hepatotoxicity (Henman, M./ (Interview/MacHale, S.) 477-478 (Osteoporosis) 192 Hepatotoxicity/Pharmacovigilance) 436-442 Avastin Book Reviews Advertising (of medicines) Avastin – further indication approved 192 Antimicrobial Pharmacodynamics in Theory and For better or for worse – medicine advertising and Avastin – further positive results as a co-treatment Clinical Practice (2nd Edition) Nightingale, C., medicine use (Zephyr) 82 for lung and renal cancers (Cancer) 234 Ambrose, P. et al 449 AED’s Awards Applications of LC-MS in Toxicology Prevention of Sudden Cardiac Death – the role of Cork-based pharmacist wins top accolade 12-13 Polettini, A. {Ed.} 118 the Community Pharmacy (Cardiac/ Inaugural IPOS Pharmacy Excellence Awards Concise Clinical Pharmacology Greenstein, B. & Eggers, S.) 247 -250 (IPOS) 17 Greenstein, A. 172 Alcohol and Pregnancy (Pregnancy) 386 International Award for Mater Hospital Dietary Supplements (3rd Edition) Mason, P. 366 Allergy Pharmacist (Mater Misericordiae Hospital) 338 Drug-Induced Diseases – Prevention, Detection Cow’s Milk Allergy in Infants (Paediatrics) 325 La Roche-Posay International award for Alan and Management Tisdale, J.E., Mille, D.A. 118 GRAZAX® - positive second year results Irvine (OLHSC) 21 Endotoxins: Pyrogens, LAL Testing and (GRAZAX®) 110 Pharmaceutical Manufacturing Technology Depyrogenation Williams, K.L. {Ed.} 368 Analgesics Awards Ceremony [TCD] (Schools) 170 Handbook of Poisonous & Injurious Plants (2nd Guidance on OTC Analgesia in Pain Practice of Pharmacy Committee: Announcement Edition) Nelson, L.S., Shih, R.D., Management Launched (OTC/Pain) 152 of Funding Awards for Practice Based Balick, M.J. 212 Versatis® - Lidocaine -medicated plaster approved Research (Practice of Pharmacy) 90-92 Irish Medicines Formulary (2nd Edition) by MHRA (Lidocaine/Versatis) 80 Cock-Wall, A. 408 Anastrozole Managing Anticoagulant Patients in the Hospital Long-term safety data for Arimidex™ Battaglia, D. {Ed.} 406 [anastrozole] reinforce patient benefits B The Maudsley Prescribing Guidelines (9th Edition) (Cancer) 66 Taylor, D., Paton, C., Kerwin, R. {Eds.} 368 Antibiotics Baggot, J. MCQs in Clinical Pharmacy Azzopardi, L.M. GPs admit over-prescribing antibiotics (Over- International Suicide Prevention Conference 226 {Ed.} 319 prescribing) 428 Suicide prevention: what can we do – as people, Neutraceuticals (2nd Edition) Lockwood, B. 366 Appointments as pharmacists? (Suicide) 400-402 Palliative Care: Core Skills and Clinical HIQA Director of Health Technology Assessment Bar coding (see Technology) Competencies Emanuel, L.L., Librach, S.L. (HIQA) 340 BD Diagnostics {Eds.} 449 Irish Pharmaceutical Healthcare Association BD’s MRSA test gets EU approval (MRSA) 238 Patient Compliance with Medications: Issues and (IPHA) 340 Benevolent Fund Opportunities Fincham, J.E. {Ed.} 450 New member of IPHA appointed to the Board of Benevolent Fund AGM 386 Pharmacy and the US healthcare System (3rd Directors (IPHA) 257 Benevolent Fund Golf Classic, 2007 282 Edition) Smith, M.I., Wertheimer, A.I., Pfizer appoints new Country Manager Benevolent Fund: let them know they’re not Fincham, J.E. {Eds.} 32 (Pfizer) 256 forgotten (Dowd, M./Interview) 451-452 Psoriasis – at your fingertips Mitchell, T., Arimidex™ (see Anastrozole) Penzer, R. 212 Rules & Guidance for Pharmaceutical Chronic Pain (see Pain) Cramp Distributors 2007 Pharmaceutical Press 366 Clarymist - New Dry Eye spray treatment Botox effective at relieving writer’s cramp Rules and Guidance for Pharmaceutical (Eyes) 79 (Botox) 66 Manufacturers and Distributors 2007 Clinical Trial/Research Results Crawford, A.M. Supplier errors in deliveries to (Orange Guide) Pharmaceutical Press 172 Trial shows benefits of blood pressure lowering the pharmacy of a large Dublin teaching hospital Stockley’s Drug Interactions 2007 Pocket treatment for over-80s (Blood Pressure) 494 (Hammond, E./Hospital Pharmacy Issue/ Companion Pharmaceutical Press 246 Clonmel Healthcare Supplier Errors) 302 Successfully Marketing Clinical Trial Results: Clonmel Healthcare’s new corporate identity 105 Creaton, G. Winning in the Healthcare Business Clonmel rebrands its consumer division – A Collaborative Study of Medication Umbach, G. 408 ClonMedica 276 Safety in Four Irish hospitals (Colohan, G./ Textbook of Pharmacoepidemiology Storm, B., Codeine Delaney, T./Harnett, B./Inter-Hospital Study/ Kimmel, S.E. {Eds.} 318-319 Young Scientist Project (2007) – Codeine Kirke, C./Medication Safety/Peer Review/ The Complete Guide to Medical Writing Addiction in Ireland (Addiction) 102 Tighe, P.) 68-73 Stuart, M.C. {Ed.} 318 Colds (see Cough) Pain control in post-operative patients Boots Collins, R. Biopharmaceuticals – the new weapon (Murphy, P.G.M./Pain) 353-356 Reckitt Benckiser acquisition of Boots Healthcare of choice in the battle against disease Crohn’s Disease International (Reckitt Benckiser) 21 (Biopharmaceuticals) 166-169 CHMP give Humira® (adalimumab) positive Botox effective at relieving writer’s cramp Colohan, G. A Collaborative Study of Medication opinion for the treatment of Crohn’s Disease (Cramp) 66 Safety in Four Irish hospitals (Creaton, G./ (Adalimumab/CHMP) 238 Bowel Delaney, T./Harnett, B./Inter-Hospital Study/ Online support for Crohn’s 428 One in three adults in Ireland not aware of bowel Kirke, C./Medication Safety/Peer Review/ Cryan, S.A. The Science behind cancer risk factors (Cancer) 64 Tighe, P.) 68-73 Biopharmaceuticals (Biopharmaceuticals/ Buprenorphine/naloxo ne Competact (New Product) 176 Moran, P.J.) 202-204 Suboxone® (buprenorphine/naloxone) – a new Computerisation CT Scanner alternative to methadone (Addiction/ Computers – anything that can go wring will go High-tech CT scanner for rapid, non-invasive Methadone) 124 wrong (Zephyr) 38 coronary imaging acquired by Mater Private Burns Conferring (Mater Private) 62 Burn Jel™ - First Aid Burn Treatment Pharmacy Showcase Research Poster Exhibition (First Aid) 78 (Pre-Registration/Research/Schools) 50-53 Buttercup Original Syrup (Coughs) 78 PSI Conferring Ceremony 2007 (PSI/ Schools) 46-48 D Showcasing of the Pre-Registration Year Research (Pre-Registration/Research/ Deasy, E. Failure mode and effect analysis to C Schools) 48-50 assess the risk associated with stocking two Contraception concentrations of Enoxaparin (Enoxaparin/ Cancer Pill to be piloted in UK pharmacies in 2008 481 Hospital Pharmacy Issue/Kilcullen, N./ Avastin – further positive results as a co-treatment Cotter, J. National Association of Hospital O’Brady, C./Risk Assessment) 311-314 for lung and renal cancers (Avastin) 234 Pharmaceutical Technicians [NAHPT] Deasy, P. Breast Cancer Awareness Month 388 (Cotter, J.) 184 Prof Patrick Deasy retires from TCD Cervical cancer vaccine recommended for all UK Cough (and Cold) Pharmaceutics Dept. (Schools) 478 girls (Vaccination) 432 Buttercup Original Syrup (Buttercup) 78 Deeny, C. Lapatinib – FDA approval as adjunct for Cough and Cold Medicines in infants: Breaking the silence 499 treatment of metastatic breast cancer inappropriate use and toxicity (Henman, M./ Delaney, T. (Lapatinib) 192 Paediatrics/Toxicity) 446-448 A Collaborative Study of Medication Safety in Late diagnosis and slow drug approval hindering Council Four Irish hospitals (Colohan, G./Creaton, G./ multiple myeloma treatment and care 109 COUNCIL REPORTS Harnett, B./Inter-Hospital Study/Kirke, C./ Long-term safe ty data for Arimidex™ December 2006 2-4 Medication Safety/Peer Review/Tighe, P.) 68-73 (anastrozole) reinforce patient benefits January 2007 42-44 Hospital Pharmacy Staffing and Workload in Irish (Anastrozole) 66 March 2007 130-132 Acute Hospitals (Hospital Staffing) 136-144 New anticancer agent improves patients’ survival April 2007 182-183 Tim Delaney Joins Commission on Patient Safety in adjuvant gastric cancer trial 236 November 2007 meeting of PSI Council 463-464 and Quality Assurance (Patient Safety) 103 One in three adults in Ireland not aware of bowel December 2007 meeting of PSI Council 464-468 Time for a change of tactics? (Letters/ cancer risk factors (Bowel) 64 GENERAL Pre-Registration) 94-96 Study demonstrates efficacy of docetaxol in A legal perspective on the new PSI council Depression prostate cancer (Docetaxol) 236 (Dowling, D./PSI) 332-336 Workplace depression campaign launched 480 Capacity Planning First Council of the New Pharmaceutical Society Dermatology Designing a capacity plan for the Aseptic of Ireland (PSI) 222 PCDS Educational Meeting on Psoriasis (PCDS/ Compounding Unit in St. James’s Hospital Minister inaugurates the new PSI – the Pharmacy Psoriasis) 60 (Aseptic Compounding/Hospital Pharmacy Issue/ Regulator (PSI) 266 Devices (Medical) O’Boyle, N./St. James’s Hospital) 303-306 PSI Council Member Profiles (PSI) 268-270 Medical Devices and Diagnostics Sector in Cardiac PSI Council News (PSI) 380 Ireland (Diagnostics/Fogarty, N.) 159-161 Irish Heart Week (IHF) 342 Counterfeiting Medical Devices Industry – Ireland (Editorial/ Prevention of Sudden Cardiac Death – the role of 2D bar code technology and the fight against Industry) 129 the Community Pharmacy (AED’s/ counterfeits (Middleton, H./Technology) 453 Diabetes Eggers, S.) 247 -250 Conference: Irish Patients’ Association [Action Ezetimibe/Simvastatin (INEGY) provides greater Celesio expands in the UK and Germany 186 against Counterfeit Medicines in Ireland] Januvia® - first in a new class of oral treatments Celluvisc (New Product) 176 (IPA) 98-100 for type 2 diabetes (Januvia®) 190 Champix Counterfeit Medicines (Editorial) 1 LDL cholesterol reduction than Atorvastatin in Champix– another aid to quit smoking Counterfeit medicines a ‘significant and growing patients with type 2 diabetes (Ezetimibe) 64 (Smoking) 108 threat to patient safety’ 430 Diagnostics NICE gives approval to Champix® on NHS Global co-operation needed to stem counterfeit Medical Devices and Diagnostics Sector in (NICE) 239 medicines 481 Ireland (Devices/Fogarty, N.) 159-161 Chemotherapy IMB Notice: Counterfeit Levitra (IMB Notices/ Disability Capacity planning for chemotherapy Levitra) 8 Guide to Independent Living in Ireland launched (Cox, R./Hospital Pharmacy Issue/McPhillips, A./ Radio Frequency Identification [RFID] in the by National Disability Group (Independent Tighe, P.) 308-310 Pharmaceutical Industry (Middleton, H./ Living) 54 Children’s Health (see Paediatrics) Technology) 357-359 Discontinuations CHMP give Humira® (adalimumab) positive Safeguarding Patients against the Threat of Brufen 200mg 215 opinion for the treatment of Crohn’s Disease Counterfeit Medicines: the Role of the Calcort 1mg and 30mg tablets 411 (Adalimumab/Crohn’s Disease) 238 Pharmaceutical Wholesaler (Costelloe, E./ Clinoril tablets 411 Chol-Aid Wholesaling) 162-164 Diprivan 1% 50ml vial 259 The Chol-Aid Cholesterol Challenge Coversyl – new formulation 36 Dovonex® Ointment 321 (Cholesterol) 80 Cow’s Milk Allergy (see Allergy) Enbrel powder and solvent for solution for Cholesterol Cox, R. Capacity planning for chemotherapy injection 411 The Chol-Aid Cholesterol Challenge (Chemotherapy/Hospital Pharmacy Issue/ Estradiol 259 (Chol-Aid) 80 McPhillips, A./Tighe, P.) 308-310 Exubera 430 Fansidar 456 EMEA GRAZAX® - positive second year results Fucidin® IV 35 EMEA confirms positive benefit-risk balance for (Allergy) 110 Gyno-Daktarin Combi-pack 456 rosiglitazone and pioglitazone (Pioglitazone/ Intivirase® 200mg hard capsule 321 Rosiglitazone) 454 Isoptin SR 240mg 200 Tablets 215 Enbrel® Sharps Container Service (Injection) 325 Kinidin Durule s 369 Enoxaparin H Mixtard® 10, Mixtard 20®, Mixtard 40® and Failure mode and effect analysis to Mixtard 50® 35 assess the risk associated with stocking two Hammond, E. Supplier errors in deliveries to MXL Capsules 369 concentrations of Enoxaparin (Deasy, E./ the pharmacy of a large Dublin teaching hospital NeoRecormon 60,000 iµ 456 Hospital Pharmacy Issue/Kilcullen, N./ (Crawford, A.M./Hospital Pharmacy Issue/ Ortho-créme™ 79 O’Brady, C./Risk Assessment) 311-314 Supplier Errors) 302 Pancrease™ 35 PREVAIL study shows enoxaparin reduces risk of Handelsman, D. Pharmaceutical industry, heal Poliomyelitis vaccine 369 VTE in stroke patients (PREVAIL/Stroke) 454 thyself (Industry) 210-211 Puregon 100IU 120 Epilepsy Harnett, B. A Collaborative Study of Medication Sustanon 259 Inovelon® granted EC marketing authorisation Safety in Four Irish hospitals (Colohan, G./ Topicycline (tetracycline) solution 79 (Inovelon®) 66 Creaton, G./Delaney, T./ Inter-Hospital Study/ Valium 2mg tablets 411 Etanercept improved nail psoriasis Kirke, C./Medication Safety/Peer Review/ Zirtek 200ml Solution 321 (Psoriasis) 234 Tighe, P.) 68-73 Dispensing Ethics Hayes, B. Medicines and Children (O’Flaherty, K./ Ethical and legal issues in Healthcare A seasonal message from the President of the Paediatrics) 444 (Roche, C.) 492 Pharmaceutical Society of Ireland 462 Standard Operating Procedures for Dispensing in EU FIP Conference Report (FIP) 404-406 Community Pharmacy (Dunne, A./ EU PHARMACY Health Impact conference 428 SOPs) 112-117 A Review of the Submission by the Health Literacy (see Literacy) DIT Pharmaceutical Society of Ireland in respect of Health Support Programme (HSP) Hickey’s Pharmacy and DIT launch “The Consultation Regarding EU Community Action Caring for the health of the healthcare Diploma in Retail Pharmacy Management” on Health Services (PSI/Stokes, C.) 88-89 professional (Interview/Leddy, B.) 382-384 (Hickeys/Training) 106 PSI represented at meeting with Commissioner Health Technology Assessment Docetaxol McCreevy (PSI) 20 The fourth hurdle: setting the standard for clinical Study demonstrates efficacy of docetaxol in REACH – new EU regulation (REACH) 228 and cost effectiveness (Interview/ prostate cancer (Cancer) 236 EU REGISTRATION (see Registration) Ryan, Dr M.) 484-486 Dowd, M. Benevolent Fund: let them know EU REGULATIONS Henman, M. they’re not forgotten (Benevolent Fund/ European law on nutrition and health claims Adverse Drug Reactions and the role of the Interview) 451 -452 (Nutrition/Walsh, O.) 452 Pharmacist – Hepatotoxicity (Adverse Drug Dowling, D. A legal perspective on the new PSI Eyes Reactions/Hepatotoxicity/ council (Council/PSI) 332-336 Clarymist - New Dry Eye spray treatment Pharmacovigilance) 436-442 Drug Payments Scheme (Clarymist) 79 Cough and Cold Medicines in infants: DPS payments by patients to rise to €90 from Ezetimibe/Simvastatin inappropriate use and toxicity (Cough/ January 2008 480 Ezetimibe/simvastatin (INEGY) provides greater Paediatrics/Toxicity) 446-448 Dry Mouth – much more than nuisance LDL cholesterol reduction than Atorvastatin in Pharmacovigilance and patient safety: lessons (O’Sullivan, E.M.) 206-208 patients with type 2 diabetes (Diabetes) 64 from nimesulide (Nimesulide/Patient Safety/ Dunne, A. Standard Operating Procedures for Ezetimibe/simvastatin provides greater lipid Pharmacovigilance) 392-394 Dispensing in Community Pharmacy modifying benefits 369 Prescriptions: safety, security and communication (Dispensing/SOPs) 112-117 (Practice of Pharmacy/Prescriptions) 488-489 Senior Practice appointment at Trinity School (Schools) 280 F Hepatotoxicity (see Toxicity) E Hickey’s Pharmacy and DIT launch “The Diploma FDA in Retail Pharmacy Management” (DIT/ Editorial FDA approved 32 new products in 2006 110 Training) 106 A changing culture (Legislation) 329 Female Health High Tech Medicines An Historic Month for Pharmacy Migraine Action Week: Focus on Women Reimbursement of Revlimid® under the High (Legislation) 129 (Migraine) 340 Tech Medicines scheme (Revlimid®) 494 A roadmap for the profession 461 FIP Conference Report (Hayes, B.) 404-406 History of Pharmacy Challenging times ahead for Hospital Pharmacy First Aid McMichael’s Medical Hall (Hospital Pharmacy/Legislation) 265 Burn Jel™ - First Aid Burn Treatment (McMichael, A.) 28-32 Counterfeit Medicines (Counterfeiting) 1 (Burns) 78 History of Pharmacy (Keogh, C.) Making patient safety a priority TCD First Aid campaign (TCP) 276 January 1907/1957 39 (Patient Safety) 377 Fitness to Practise (see Practice of Pharmacy) February 1907/1957 83 Medical Devices Industry – Ireland (Devices/ Flexitol Heel Balm 320 March 1907/1957 126 Industry) 129 Fluanxol tablets – colour change 322 April 1907/1957 179 Nurse prescribing – new regulations (Legislation/ Fogarty, N. Medical Devices and Diagnostics May 1907/1957 219 Prescribing) 41 Sector in Ireland (Devices/Diagnostics) 159-161 June 1907/1957 263 Pharmacy Bill 2007 (Legislation) 85 FSAI July 1907/1957 327 The new Pharmaceutical Society of Ireland FSAI advises on national policy for vitamin D August/September 1907/1957 374 (PSI) 221 supplementation for infants (Paediatrics/ October 1907/1957 414 The new PSI Council – a milestone 265 Vitamin D) 230 November 1907/1957 458 The Risks of Polypharmacy (Polypharmacy) 181 Consumer protection key focus for new chairman December 1907/1957 Time to change perceptions 417 of Food Safety Authority of Ireland 134 & January 1908/1958 498 Editor’s Note (O’Flaherty, K.) 330, 378, 418, 462 Fucibet® Lipid – a new formulation 260 HIQA Director of Health Technology Assessment Eggers, S. (Appointments) 340 A Pharmacy-led approach to Weight Management Hospital Pharmacy (General) (Weight Management) 344-352 Challenging times ahead for Hospital Pharmacy Prevention of Sudden Cardiac Death – G (Editorial/Legislation) 265 the role of the Community Pharmacy (AED’s/ Hospital Pharmacy Staffing and Workload in Irish Cardiac) 247-250 Gardasil® demonstrates cross-protection against Acute Hospitals (Delaney, T.) 136-144 Elderly additional virus types 413 Hospital Pharmacy Issue (July) Polypharmacy and Pharmaceutical Care of the Generics Capacity planning for chemotherapy Elderly (Manley, P./Peer Review/ The Generics Sector of the Pharma Industry, and (Chemotherapy/Cox, R./McPhillips, A./ Polypharmacy) 194-201 its Importance to Ireland Inc. (Industry/ Tighe, P.) 308-310 Eli Lilly O’Riordan, R.) 164-165 Designing a capacity plan for the Aseptic Lilly’s new clinical trial of Xigris® Genetics Compounding Unit in St. James’s Hospital (Xigris®) 109 Genetics and the blame game (Zephyr) 218 (Aseptic Compounding/Capacity Planning/ EMCDDA Graduates O’Boyle, N./St. James’s Hospital) 303-306 EMCDDA Annual Report 2006 10 Landmark occasion for UCC’s School of Failure mode and effect analysis to assess the risk EMCDDA releases 2007 annual report 480 Pharmacy (Schools) 20 associated with stocking two concentrations of Enoxaparin (Deasy, E./Enoxaparin/Kilcullen, N./ Interview Council Nominees (Editorial) 183 O’Brady, C./Risk Assessment) 311-314 Benevolent Fund: let them know they’re not Nurse prescribing – new regulations (Editorial/ HPAI Annual Education Conference 2007 forgotten (Benevolent Fund/Dowd, M.) 451-452 Prescribing) 41 (HPAI) 290-298 Caring for the health of the healthcare ‘Official’ response to HPAI Queries Supplier errors in deliveries to the pharmacy of a professional (Leddy, B./Health Support (Editorial) 183 large Dublin teaching hospital Programme) 382-384 Pharmacy Bill 2007 (Editorial) 85 (Crawford, A.M./Hammond, E./ Fostering the principles of good governance Pharmacy Bill 2007 132 Supplier Errors) 302 (Audit Committee/MacHale, S.) 477-478 Pharmaceutical Society President optimistic about HPAI The fourth hurdle: setting the standard for clinical new legislation after 130-year wait (PSI) 86 HPAI Annual Education Conference 134 and cost effectiveness (Health Technology Remarkable Pharmacists fit the Bill HPAI Annual Education Conference 2007 Assessment/Ryan, Dr M.) 484-486 (Zephyr) 178 (Hospital Pharmacy Issue) 290-298 Helping industry to meet growing healthcare Letters HSE needs (Industry/McLaughlin, J.) 154-158 Advertising and scientific analysis 390 HSE launches Stop Smoking Campaign IPA A matter of opinion 482 (Smoking) 16 Conference: Irish Patients’ Association [Action Gender Conscious 435 HumaPen™ Luxura replaces HumaPen™ against Counterfeit Medicines in Ireland] HSE Reimbursement Decision 434-435, 481-482 Ergo 320 (Counterfeiting) 98-100 Pharmacy as a business 482 Humira (see Adalimu mab) IPHA Pharmacy graduates 96 Irish Pharmaceutical Healthcare Association Pharmacy supermarkets 390 (Appointments) 340 Resignations from the Council 316 IPHA welcomes EC’s Drug Discovery Time for a change of tactics? (Delaney, T./ I Initiative 230 Pre-Registration) 94-96 IPHA welcome R&D tax credit as benefiting Zephyr’s ‘Let’s get pharmacovigilating’ 96 IMB researchers and patients (R&D) 16 Levitra Harmful TCM products found in Ireland New member of IPHA appointed to the Board of IMB Notice: Counterfeit Levitra (Counterfeiting/ (TCM) 428 Directors (Appointments) 257 IMB Notices) 8 Irish Medicines Board welcomes Court IPOS Lidocaine ruling 336 Inaugural IPOS Pharmacy Excellence Awards Versatis® - Lidocaine-medicated plaster approved IMB releases 2006 report 478 (Awards) 17 by MHRA (Analgesics/Versatis) 80 IMB Working Group in relation to classification IHF Literacy of method of supply of veterinary vaccines – PSI Irish Heart Week (Cardiac) 342 Literacy awards 432 submission (PSI/Veterinary Medicine) 272 Isotretinoin Understanding health, literally (Zephyr) 459 IMB Notices Practice Notice: Prescribing and Dispensing of Lundbeck – Art Against Stigma 338 Alert on harmful herb 386 Isotretinoin (Roaccutane®) 8 Counterfeit citalopram tablets 386 IMB launches new website with online ADR reporting (ADR) 432 M IMB Notice: Counterfeit Levitra (Counterfeiting/ J Levitra) 8 MacHale, S. Fostering the principles of good IMB - Product Recall (Taxol & Vepesid) 152 Januvia® - first in a new class of oral treatments governance (Audit Committee/ IMB suspends marketing of medicines including for type 2 diabetes (Diabetes) 190 Interview) 477-478 Nimesulide (Nimesulide) 222 Jarvis, S. Omega-3s – nature’s miracle or hype? Malaria Imogas – McNeil Healthcare Launch 320 (Omega-3s) 360-363 Incidence of Irish malaria cases increases Indapamide (see Perindopril) (Travel Medicine) 232 Independent Living Mater Misericordiae Hospital Guide to Independent Living in Ireland launched International Award for Mater Hospital by National Disability Group (Disability) 54 K Pharmacist (Awards) 338 Independent Pharmacy Ownership Scheme Mater Private (see IPOS) Keogh, C. History of Pharmacy, Jan-Dec 2007 High-tech CT scanner for rapid, non-invasive Industry Kilcullen, N. Failure mode and effect analysis to coronary imaging acquired by Mater Private Helping industry to meet growing healthcare assess the risk associated with stocking two (CT Scanner) 62 needs (Interview/McLaughlin, J.) 154-158 concentrations of Enoxaparin (Deasy, E./ Mater Private acquires new state-of-the-art Medical Devices Industry – Ireland (Devices/ Enoxaparin/Hospital Pharmacy Issue/ radiotherapy system (Radiotherapy) 18 Editorial) 129 O’Brady, C./Risk Assessment) 311-314 McCullagh, M.L. Mental Health Act 2001 Pharmaceutical industry, heal thyself Kirke, C. (Legislation/McCullagh, M.L.) 24-26 (Handelsman, D.) 210-211 A Collaborative Study of Medication McLaughlin, J. Helping industry to meet The Generics Sector of the Pharma Industry, and Safety in Four Irish hospitals (Colohan, G./ growing healthcare needs (Interview/ its Importance to Ireland Inc. (Generics/ Creaton, G./Delaney, T./Harnett, B./Inter-Hospital McLaughlin, J.) 154-158 O’Riordan, R.) 164-165 Study/Medication Safety/Peer Review/ McLoughlin, A. Industry Organisations Tighe, P.) 68-73 At Last: The Pharmacy Bill 2007, An Introduction PMII 171 Medication Safety Briefing (Medication Safety/ to the legislation (Legislation/PSI) 86-87 MRII 171 Practice of Pharmacy) 490 McMichael, A. McMichael’s Medical Hall INEGY® (see Ezetimibe/Simvastatin) (History of Pharmacy) 28-32 Infant Health (see Paediatrics) McPhillips, A. Capacity planning for Infliximab chemotherapy (Chemotherapy/Cox, R./ The EU approves shortened infusion for L Hospital Pharmacy Issue/Tighe, P.) 308-310 Infliximab 109 Medication Safety Influenza Labelling A Collaborative Study of Medication Safety in Influenza season: are we ready? Label translation website for pharmacies 14 Four Irish hospitals (Colohan, G./Creaton, G./ (O’Flaherty, K.) 395-398 Lapatinib – FDA approval as adjunct for treatment Delaney, T./Harnett, B./Inter-Hospital Study/ Oseltamivir could halve pandemic influenza death of metastatic breast cancer (Cancer) 192 Kirke, C./Peer Review/Tighe, P.) 68-73 toll (Oseltamivir/Pandemic) 286 Lamotrigine Medication Safety Briefing Information Meetings Lamoro Tablets – Pinewood Healthcare 214 (Practice of Pharmacy/Kirke, C.) 490 PSI to hold Regional Information Meetings Leddy, B. Caring for the health of the healthcare Medicom (PSI) 331 professional (Interview/Health Support System Solutions and Medicom Merge Injection Programme) 382-384 (Mergers/System Solutions) 56 Enbrel® Sharps Container Service (Enbrel) 325 Legislation Meningitis Inovelon® granted EC marketing authorisation A changing culture (Editorial) 329 Pneumococcal vaccination for children (Epilepsy) 66 An Historic Month for Pharmacy (Vaccination) 190 Inter-Hospital Study (Editorial) 129 Mental Health A Collaborative Study of Medication Safety in At Last: The Pharmacy Bill 2007, An Introduction Mental Health Act 2001 (Legislation/ Four Irish hospitals (Colohan, G./Creaton, G./ to the legislation (McLoughlin, A./PSI) 86-87 McCullagh, M.L.) 24-26 Delaney, T./Harnett, B./Kirke, C./ Challenging times ahead for Hospital Pharmacy Mental Health Awareness 432 Medication Safety/Peer Review/Tighe, P.) 68-73 (Editorial/Hospital Pharmacy) 265 Merck Mental Health Act 2001 (McCullagh, M.L./ ABC’s of Vitamin D Information Campaign Mental Health) 24-26 (Vitamin D) 176 Mergers O’Boyle, N. Designing a capacity plan for the Paediatric Pain Guide for parents System Solutions and Medicom Merge Aseptic Compounding Unit in St. James’s (Paediatrics) 215 (Medicom/System Solutions) 56 Hospital (Aseptic Compounding/Capacity Pain Awareness Campaign 18 Methadone Planning/Hospital Pharmacy Issue/ Pain control in post-operative patients Suboxone® (buprenorphine /naloxone) – a new St. James’s Hospital) 303-306 (Murphy, P.G.M./Creaton, G.C.) 353-356 alternative to methadone (Addiction/ O’Brady, C. Failure mode and effect analysis to Pandemic Buprenorphine) 124 assess the risk associated with stocking two Oseltamivir could halve pandemic influenza death Microbiology concentrations of Enoxaparin (Deasy, E./ toll (Influenza/Oseltamivir) 286 Microbiological Test Methods and the European Enoxaparin/Hospital Pharmacy Issue/ Pathak, K. RCSI remembers pharmacist Kiran Pharmacopoeia (Pharmacopoeia/ Kilcullen, N./Risk Assessment) 311-314 Pathak 430 Morris, J.M.) 253-255 O’Brien, C. Impact of a community pharmacy- Patient Safety Middleton, H. directed weight management programme on Tim Delaney Joins Commission on Patient Safety 2D bar code technology and the fight against blood pressure findings (Blood Pressure/Weight and Quality Assurance (Delaney, T.) 103 counterfeits (Counterfeiting/Technology) 453 Management/Obesity) 240-246 Making patient safety a priority (Editorial) 377 New pharmaceutical pricing regime in Ireland Office of Tobacco Control (OTC) Patient Safety Conference – focus on medical (Pricing) 58-60 Survey on Tobacco use by Children errors 390 Radio Frequency Identification [RFID] in the and Youth 14 Pharmacovigilance and patient safety: lessons Pharmaceutical Industry (Counterfeiting/ O’Flaherty, K. from nimesulide (Henman, M./ Technology) 357-359 Editor’s Note 330, 378, 418, 462 Pharmacovigilance/Nimesulide) 392-394 Migraine Action Week: Focus on Women Influenza season: are we ready? PCDS (Female Health) 340 (Influenza) 395-398 PCDS Educational Meeting on Psoriasis Minor Ailments Campaign launched 390 Medicines and Children (Paediatrics/ (Dermatology/Psoriasis) 60 MMR Dispensing) 444 Peer Review Free MMR vaccine for students Old PSI (see PSI) A Collaborative Study of Medication Safety in (Vaccination) 386 O’Malley, T. No Pharmacist in new Dáil 274 Four Irish hospitals (Colohan, G./Creaton, G./ Mount Carmel Hospital [Dublin] undertakes Omega-3s – nature’s miracle or hype? Delaney, T./Harnett, B./Inter-Hospital Study/ major redevelopment programme 13 (Jarvis, S.) 360-363 Kirke, C./Medication Safety/Tighe, P.) 68-73 Moran, P.J. The Science behind Orencia® (abatacept) - treatment for RA Polypharmacy and Pharmaceutical Care of the Biopharmaceuticals (Biopharmaceuticals/ (Arthritis) 371 Elderly (Elderly/Manley, P./ Cryan, S.A.) 202-204 O’Riordan, R. The Generics Sector of the Pharma Polypharmacy) 194-201 Morris, J.M. Microbiological Test Methods and Industry, and its Importance to Ireland Inc. Perindopril the European Pharmacopoeia (Pharmacopoeia/ (Generics/Industry) 164-165 ADVANCE study shows benefits of perindopril/ Microbiology) 253-255 Oseltamivir indapamide (ADVANCE) 454 Murphy, P.G.M. Pain control in post-operative Oseltamivir could halve pandemic influenza death Pernaton Gel – promotion campaign 78 Patients (Creaton, G.C./Pain) 353-356 toll (Influenza/Pandemic) 286 Pfizer MRSA Osteoporosis Pfizer appoints new Country Manager BD’s MRSA test gets EU approval (BD Bonviva® studies show significant benefit in (Appointments) 256 Diagnostics) 238 reducing risk of non-vertebral fractures Pfizer Health Index results 388 Myeloma (see Cancer) (Bonviva®) 192 Pharmacist Awards (see Awards) New osteoporosis treatment available – Pharmacopoeia Preotact® 373 Microbiological Test Methods and the European Protelos effective in post menopausal osteoporotic Pharmacopoeia (Microbiology/ N women at five years (Protelos®) 234 Morris, J.M.) 253-255 O’Sullivan, E.O. Dry Mouth – much more than Pharmacovigilance NAHPT nuisance (Dry Mouth) 206-208 Adverse Drug Reactions and the role of the NAHPT AGM 60 OTC Pharmacist – Hepatotoxicity (Adverse Drug National Association of Hospital Pharmaceutical Campaign for safer use of OTC pain Reactions/Henman, M./ Technicians [NAHPT] (Cotter, J.) 184 medication 342 Hepatotoxicity) 436-442 Naloxone (see Buprenorphine) Guidance on OTC Analgesia in Pain Pharmacovigilance and patient safety: lessons National Pharmacy Summit (see Summit) Management Launched (Analgesics/Pain) 152 from nimesulide (Henman, M./Patient Safety/ NCPE’s positive recommendation for Tysabri OTC to POM (see POM) Nimesulide) 392-394 (Tysabri) 239 Overactive bladder (OAB) Pharmacy Act 2007 New Product New OAB treatment available (Propiverine) 456 Council Nominees (Legislation) 183 Celluvisc 176 Over-prescribing ‘Official’ response to HPAI Queries Competact 176 GPs admit over-prescribing antibiotics (Legislation) 183 New PSI (see PSI) (Antibiotics) 428 Pharmacy Bill (see Legislation) New Zealand Pharmacy Pharmaplaz (Athlone) and Samaritan Pharma sign Nexium® Drug Development Agreement 256 NICE gives approval to Champix® on NHS Pioglitazone (Champix®) 239 P EMEA confirms positive benefit-risk balance for Nimesulide rosiglitazone and pioglitazone (EMEA/ IMB suspends marketing of medicines including Paediatrics Rosiglitazone) 454 Nimesulide (IMB Notices) 222 Cough and Cold Medicines in infants: PMI Nimesulide withdrawal – too little, too late? inappropriate use and toxicity (Cough/ ‘Healthcare Provison for the Future’ – PMI (Zephyr) 262 Henman, M./Toxicity) 446-448 meeting 226 Pharmacovigilance and patient safety: lessons Cow’s Milk Allergy in Infants (Allergy) 325 Point of Care from nimesulide (Henman, M./Patient Safety/ FSIA advises on national policy for vitamin D Reflotron Plus – on the spot blood test results Pharmacovigilance) 392-394 supplementation for infants (FSIA/ (Blood Tests/Reflotron Plus) 321 Novartis launches compliance programme for Vitamin D) 230 Polypharmacy hypertensive patients 413 Medicines and Children (Dispensing/ Polypharmacy and Pharmaceutical Care of the Nutrition O’Flaherty, K.) 444 Elderly (Elderly/Manley, P./ European law on nutrition and health claims Paediatric Pain Guide for parents (Pain) 215 Peer Review) 194-201 (EU Regulations/Walsh, O.) 452 Singulair now available for children aged 2-14 The Risks of Polypharmacy (Editorial) 181 years with mild persistent Asthma POM (OTC to) (Asthma/Singulair) 36, 81 UK proposal to switch Pseudoephedrine to POM SMA launches new professional healthcare (Pseudoephedrine/UK Pharmacy) 186 O website (SMA) 338 Practice of Pharmacy Pain/Pain Management Fitness to Practise: a new beginning (Zephyr) 326 Obesity Clonmel Healthcare launch treatment for chronic Medication Safety Briefing (Medication Safety/ Impact of a community pharmacy-directed weight anal fissure pain 372 Kirke, C.) 490 management programme on blood pressure Efficacy and tolerability of Tapentadol in Chronic Pharmacy and road safety (Road Safety) 486 findings (Blood Pressure/O’Brien, C./ Pain Treatment (Tapentadol) 284 Practice of Pharmacy Committee: Announcement Weight Management) 240-246 Guidance on OTC Analgesia in Pain of Funding Awards for Practice Based Obituary Management Launched (Analgesics/OTC) 152 Research (Awards) 90-92 Tom Farmer, FPSI 316 Nycomed launch new fentanyl patch for chronic Pharmacy practice self-audit document Tom O’Brien 418 pain 373 published 378 Prescriptions: safety, security and communication Q Pharmaceutical Manufacturing Technology (Henman, M./Prescriptions) 488-489 Awards Ceremony [TCD] (Awards) 170 Pregnancy Pharmacy Showcase Research Poster Exhibition Alcohol and Pregnancy (Pregnancy) 386 (Conferring/Pre-Registration/Research) 50-53 Preotact® - new osteoporosis treatment 373 R Prof Patrick Deasy retires from TCD Pre-Registration Pharmaceutics Dept. (Deasy, P.) 478 Pharmacy Showcase Research Poster Exhibition Radiotherapy RCSI School of Pharmacy, Ulster Bank (Conferring/Research/Schools) 50-53 Mater Private acquires new state-of-the-art Lecture 134 Showcasing of the Pre-Registration Year radiotherapy system (Mater Private) 18 School of Pharmacy Research Bursary Research (Conferring/Research/Schools) 48-50 RCSI (see Schools) (Research) 228 Time for a change of tactics? (Delaney, T./ REACH – new EU regulation (EU Pharmacy) 228 Senior Practice appointment at Trinity School Letters) 94-96 Reckitt Benckiser (Henman, Dr. M.) 280 Prescribing (Nurse/Midwife) Reckitt Benckiser acquisition of Boots Healthcare Showcasing of the Pre-Registration Year Nurse prescribing – new regulations (Editorial/ International (Boots) 21 Research (Conferring/Pre-Registration/ Legislation) 41 Reflotron Plus – on the spot blood test results Research) 48-50 Prescriptions (Blood Tests/Point of Care) 321 UCC School of Pharmacy new post-grad Prescriptions: safety, security and communication Regional Meetings (see PSI) course 432 (Henman, M./Practice of Pharmacy) 488-489 Registration (see PSI) UCD offers new MBA in Health Care PREVAIL study shows enoxaparin reduces risk of Remicade® (see Infliximab) Management 186 VTE in stroke patients (Enoxaparin/Stroke) 454 Research Security Pricing Pharmacy Showcase Research Poster Exhibition Security Assessment Template for Pharmacists New pharmaceutical pricing regime in Ireland (Conferring/Pre-Registration/Schools) 50-53 Launched (PSI) 52 (Middleton, H.) 58-60 School of Pharmacy Research Bursary Seretide™ Product Recall (Schools) 228 COPD patients benefit from Seretide™ Complete® MoisturePLUS 259 Showcasing of the Pre-Registration Year (Pulmonary Disease) 108 Trasylol® (aprotinin injection) 456 Research (Conferring/Pre-Registration/ Shop-fitting Propiverine Schools) 48-50 Pharmafit appointed sole distributor for New OAB treatment available (Overactive Revlimid® Pharmashelve in Ireland 146 bladder) 456 Reimbursement of Revlimid® under the High Simvastatin (see Ezetimibe/Simvastatin) Protelos® Tech Medicines scheme (High Tech Singulair now available for children aged 2-14 Protelos effective in post menopausal osteoporotic Medicines) 494 years with mild persistent Asthma women at five years (Osteoporosis) 234 R&D (Research and Development) (Asthma/Paediatrics) 36, 81 Pseudoephedrine Astellas European Foundation support TCD SMA launches new professional healthcare UK proposal to switch Pseudoephedrine to POM School of Pharmacy research website (Paediatrics) 338 (POM/UK Pharmacy) 186 (Astellas/Schools) 102 Smoking PSI IPHA welcome R&D tax credit as benefiting Champix – another aid to quit smoking 108 2007 EU Registration Periods and Deadlines 6 researchers and patients (IPHA) 16 HSE launches Stop Smoking Campaign 2nd Annual Pharmacy Summit (Summit) 336 RFID (see Technology) (HSE) 16 A legal perspective on the new PSI council Risk Assessment SOPs (Council/Dowling, D.) 332-336 Failure mode and effect analysis to Standard Operating Procedures for Dispensing in A Review of the Submission by the assess the risk associated with stocking two Community Pharmacy (Dispensing/ Pharmaceutical Society of Ireland in respect of concentrations of Enoxaparin (Deasy, E./ Dunne, A.) 112-117 Consultation Regarding EU Community Action Enoxaparin/Hospital Pharmacy Issue/ St. James’s Hospital on Health Services (EU/Stokes, C.) 88-89 Kilcullen, N./O’Brady, C.) 311-314 Designing a capacity plan for the Aseptic At Last: The Pharmacy Bill 2007, An Introduction Roaccutane® (see Isotretinoin) Compounding Unit in St. James’s Hospital to the legislation (Legislation/ Road Safety (Aseptic Compounding/Capacity Planning/ McLoughlin, A.) 86-87 Pharmacy and road safety Hospital Pharmacy Issue/O’Boyle, N.) 303-306 First Council of the New Pharmaceutical Society (Practice of Pharmacy) 486 St. Michael’s House Open Training College of Ireland (Council) 222 Rosiglitazone Stokes, C. A Review of the Submission by the IMB Working Group in relation to classification EMEA confirms positive benefit-risk balance for Pharmaceutical Society of Ireland in respect of of method of supply of veterinary vaccines – PSI rosiglitazone and pioglitazone (EMEA/ Consultation Regarding EU Community Action submission (IMB/Veterinary Medicine) 272 Pioglitazone) 454 on Health Services (EU/PSI) 88-89 Minister inaugurates the new PSI – the Pharmacy RPSGB Stroke Regulator (Council) 266 RPSGB Register – facts and figures PREVAIL study shows enoxaparin reduces risk of More than 50 new pharmacy openings (UK Pharmacy) 102 VTE in stroke patients (Enoxaparin/ in 2007 481 Ryan, Dr M. The fourth hurdle: setting the PREVAIL) 454 Overview of the year that was 2007 463 standard for clinical and cost effectiveness Suboxone® (see Buprenorphine) Pharmaceutical Society News 468-476 (Health Technology Assessment/ Suicide Pharmaceutical Society President optimistic Interview) 484-486 International Suicide Prevention Conference 226 about new legislation after 130-year wait Suicide prevention: what can we do – as people, (Legislation) 86 as pharmacists? (Baggot, J.) 400-402 PSI Conferring Ceremony 2007 (Conferring/ Summit Schools) 46- 48 S 2nd Annual Pharmacy Summit (PSI) 336 PSI Council Member Profiles (Council) 268-270 Preview of National Pharmacy Summit 379 PSI Council News (Council) 380 Safety Notices (see also IMB Notices) Second National Pharmacy Summit PSI represented at meeting with Commissioner Botulinum toxins – important safety Supplier Errors McCreevy (EU Pharmacy) 20 notification 370 Supplier errors in deliveries to the pharmacy of a PSI News – Regional Meetings Report 426 EMEA recommendation: Acomplia 370 large Dublin teaching hospital Security Assessment Template for Pharmacists Safety of Wart Removal products 370 (Crawford, A.M./Hammond, E./ Launched (Security) 52 Sahm, L. Hospital Pharmacy Issue) 302 The new Pharmaceutical Society of Ireland Beyond the Pale (Schools) 104, 223-224 Systems Solutions (Editorial) 221 Sam McCauley Chemists Group – new System Solutions and Medicom Merge Psoriasis appointments 280 (Medicom/Mergers) 56 Etanercept improved nail psoriasis Schools (Psoriasis) 234 Annual Schools of Pharmacy Conference PCDS Educational Meeting on Psoriasis 2007 251-252 (Dermatology/PCDS) 60 Astellas European Foundation support TCD T Pulmonary Disease School of Pharmacy research COPD patients benefit from Seretide™ (Astellas/R&D) 102 Tapentadol (Seretide™) 108 Beyond the Pale [UCC] (Sahm, L.) 104, 223-224 Efficacy and tolerability of Tapentadol in Chronic Purinol (Allopurinol) – new formulation & tablet First Pharmacy graduates conferred at University Pain Treatment (Pain) 284 Markings 322 College Cork [UCC] 274 Taxol (see IMB Notices) Landmark occasion for UCC’s School of TB (see Tuberculosis) Pharmacy (Graduates) 20 TCD (see Schools) PSI Conferring Ceremony 2007 (Conferring/ TCP First Aid campaign (TCP) 276 PSI) 46-48 TCM WEEE Regulations - Advisory Note 331-332 Harmful TCM products found in Ireland Weight Management (IMB) 428 A Pharmacy-led approach to Weight Management Technology (Eggers, S.) 344-352 2D bar code technology and the fight against Impact of a community pharmacy-directed weight counterfeits (Counterfeiting/Middleton, H.) 453 management programme on blood pressure Radio Frequency Identification [RFID] in the findings (Blood Pressure/Obesity/ Pharmaceutical Industry (Counterfeiting/ O’Brien, C.) 240-246 Middleton, H.) 357-359 Wholesaling Tighe, P. Safeguarding Patients against the Threat of A Collaborative Study of Medication Counterfeit Medicines: the Role of the Safety in Four Irish hospitals (Colohan, G./ Pharmaceutical Wholesaler (Costelloe, E./ Creaton, G./Delaney, T./Harnett, B./Inter-Hospital Wholesaling) 162-164 Study/Kirke, C./Medication Safety/ Peer Review) 68-73 Capacity planning for chemotherapy (Chemotherapy/Cox, R./Hospital Pharmacy Issue/ X McPhillips, A.) 308-310 Toxicity Xerostomia (see Dry Mouth) Adverse Drug Reactions and the role of the Xigris® Pharmacist – Hepatotoxicity (Adverse Drug Lilly’s new clinical trial of Xigris® Reactions/Henman, M./ (Xigris®) 109 Pharmacovigilance) 436-442 Cough and Cold Medicines in infants: inappropriate use and toxicity (Cough/ Henman, M./ Paediatrics) 446-448 Y Training Hickey’s Pharmacy and DIT launch “The Young Scientist Project (2007) – Codeine Diploma in Retail Pharmacy Management” Addiction in Ireland (Addiction/Codeine) 102 (DIT/Hickeys) 106 Travel Medicine Incidence of Irish malaria cases increases (Malaria) 232 Z Travel Medicines – NMIC 232 Travel Vaccine Information Website 232 Zephyr (Deeny, C.) Tuberculosis Competition and collective bargaining 126 TNF-α antagonists and the risk of tuberculosis Computers – anything that can go wring will go [TB] 386 wrong (Computerisation) 38 Tysabri Cures, frogs, warts and all 415 Latest results from Tysabri clinical trial 412 Fitness to Practise: a new beginning (Practice of NCPE’s positive recommendation for Tysabri Pharmacy) 326 (NCPE) 239 For better or for worse – medicine advertising and medicine use (Advertising) 82 Genetics and the blame game (Genetics) 218 Nimesulide withdrawal – too little, too late? U (Nimesulide) 262 Remarkable Pharmacists fit the Bill UCC (see Schools) (Legislation) 178 UK Pharmacy The business of Pharmacy 375 RPSGB Register – facts and figures Understanding health, literally (Literacy) 459 (RPSGB) 102 UK proposal to switch Pseudoephedrine to POM (POM/Pseudoephedrine) 186

Vaccination Cervical cancer vaccine recommended for all UK girls (Cancer) 432 Pneumococcal vaccination for children (Meningitis) 190 Valsartan shows benefits in Japanese study 412 Vepesid (see IMB Notices) Versatis® - Lidocaine -medicated plaster approved by MHRA (Analgesics/Lidocaine) 80 Veterinary Medicine IMB Working Group in relation to classification of method of supply of veterinary vaccines – PSI submission (IMB/PSI) 272 Vitamin D ABC’s of Vitamin D Information Campaign (Merck) 176 FSIA advises on national policy for vitamin D supplementation for infants (FSIA/ Infant Health) 230 VIVAS Health website 226

Walsh, O. European law on nutrition and health claims (EU Regulations/Nutrition) 452 LEGEND:

BC Back Cover FP Full Page ADVERTISING INDEX HP Half Page IBC Inside Back Cover IFC Inside Front Cover VOLUME 85 QP Quarter Page EP Eighth Page

A Perdamel 491 FP I Cruinn Diagnostics Ltd. Alcon Reflotron Plus 323 FP IPOS 6 FP ICapsR 407 FP 347 FP 53 FP Alchemy IFC Nov FP 389 FP 97 FP IFC Dec FP BC Nov FP 141 FP Astellas 493 FP Xcelerate 33 FP Difene 307 FP 67 FP Ateam Health Recruitment IBC Jan FP 111 FP IBC Feb FP D 153 FP IBC Mar FP 333 FP IBC Apr FP Dept. of Health & Children 101 FP Irish Health Trade Association 26 QP IBC May FP Douglas Newman Good 26 QP Irish Prison Services IBC Jul FP Pharmacist Wanted 427 HP IBC Aug FP International Frankfurter Messe 383 FP E Beautyworld 427 HP 423 FP 479 HP 467 FP Eireann Healthcare Publications Know Your Medicine 191 FP Electramed 293 FP J B IBC Oct FP Johnson & Johnson 495 FP Barry Packaging 22 QP 450 QP F 496 QP K Baxter Healthcare 147 HP Fannin BC Jul FP 279 FP Findapharmacist.ie 150 FP Beacon Hospital 205 HP 213 FP L Beiersdorf 265 FP Eucerin 119 QP 275 FP LABO Europa Biotene 208 QP 367 FP Botoina 95 FP Bon Secours Health System 105 HP First Active BC Aug FP 139 FP Boots 25 FP First Medical 193 FP 51 FP Pharmacist Awards BC Jun FP 343 FP 121 FP 273 FP 437 FP 137 FP Crescina 235 FP 189 FP 387 FP 225 FP G Lilly 267 FP Byetta 207 FP 443 FP Galway Clinic 119 QP 241 FP 487 FP GlaxoSmithKline Consumer Healthcare 339 FP B/Braun Flioxonase 145 FP Zyprexa (Olanzaprine) 309 FP CAPS 315 FP 227 FP Lundbeck 284 HP Lexapro BC May FP Niquitin 15 FP Lyle & Co. 22 QP C 125 FP 81 QP IBC Dec FP 119 QP Cahill May Roberts BC Mar FP Panadol 29 FP 173 QP IFC Apr FP 63 FP 211 QP IFC May FP IFC Mar FP 238 QP IFC Jun FP 99 FP 306 QP IFC Oct FP 143 FP 372 QP Focus Finance IFC Jul FP 167 FP 413 QP IFC Aug FP 197 FP 451 QP Chefaro Ireland Limited 199 FP 496 QP Abidec 23 FP Zovirax 107 FP 65 FP 277 FP Buttercup 27 FP 445 FP M 61 FP 469 FP Hemoclin 77 FP Mary O’Brien (Recruitment) 76 HP Lyclear BC Jan FP McNeil Ltd. 59 FP H Benylin 4Flu 9 FP 351 FP 429 FP Metatone 37 FP Health and Safety Authority 471 FP 69 FP REACH 57 FP Benylin Cough Syrup 7 FP Clonmel Healthcare 93 FP 349 FP 393 FP 237 FP Health Service Executive 120 EP 431 FP 385 FP 257 QP 475 FP Clonmedica 269 FP 352 QP 447 FP Hiltons Pharmacy 250 QP

Imogas 271 FP R X 341 FP 391 FP Reckitt Benckiser Immodium Plus 335 FP Nurofen 396 HP Y 403 FP Ricesteele Sudacare 175 QP Rubex 283 FP Sudafed 19 FP Z 433 FP Roche Pharmaceuticals 483 FP MabThera (Rituximab) 285 FP Medical Recruitment Specialists Rosemont Pharmaceuticals Ltd. 195 FP 204 HP Rowex Medical Trade Show 2007 71 FP Ramilo 297 FP 115 FP 157 FP Medisource 35 QP S 79 QP 119 QP Safety-Tec 249 QP 173 QP Sanofi Aventis 291 FP 215 QP Sanofi Aventis/Bristol Myers Squibb 259 QP PAD 425 FP 321 QP Servier 369 QP Coversyl 49 FP 411 QP Protelos 301 FP 457 FP Sherry Fitzgerald McMahon 476 HP 497 HP Shire Pharmaceuticals Ltd. Medpharma Calcichew-D3 Forte 287 FP

Optisal 372 QP Exputex 47 FP Merck, Sharp & Dohme 91 FP Arcoxia 233 FP 135 FP Fosavance 231 FP 185 FP Januvia 229 FP 337 FP 281 FP 399 FP 465 FP Solvay N Influvac 397 FP Speko Distributors Nutricia Clinical Care Kodak BC Oct FP Calogen IFC Jan FP SSL Healthcare Ireland 177 FP Full Marks Solution BC Feb FP Infatrini 299 FP 88 FP Nycomed 151 FP 133 FP

O T

Our Lady’s Children’s Hospital 224 HP Technopharm 187 FP Teva Pharmaceuticals Ireland 485 FP Tone & Slim 350 QP P Trinity College Dublin 76 QP 120 QP Pfizer Consumer Healthcare 209 FP Calpol/Provin 11 FP 278 HP 45 FP Nicorette IFC Feb FP 441 FP U BC Dec FP Pharmafit BC Apr FP UCC 117 HP Pinewood Healthcare Ulster Bank 17 HP Minosil IBC Nov FP Unicare 149 FP Premium Distribution United Drug Wholesale 317 FP Prinoc 75 FP Uvistat 123 QP

Q V

Quinn-life 55 FP 381 FP W

Acknowledgement of contributors –

January to December 2007

Jennifer Baggot Sabine Eggers Bernard Leddy Carol O’Brady James Barlow Noel Fogarty Sean MacHale Ciara O’Brien Ronan Collins Ailish Hagerty Paul Manley Caitriona O’Driscoll Geraldine Colohan Patricia Ging Tom McAuliffe Kate O’Flaherty Edel Costelloe Elaine Hammond Sinead McCool Rory O’Riordan Roisin Cox David Handelsman Mark McCullagh Eleanor O’Sullivan

Anne Marie Crawford Bernadette Harnett Ann McGee Cicely Roche

Geraldine Creaton Val Harte John McLoughlin Mairin Ryan

John Cryan Martin Henman Aidan McMichael Laura Sahm Sally-Ann Cryan Brendan Hayes Allison McPhillips Cheryl Stokes Evelyn Deasy Sarah Jarvis Helen Middleton Paul Tighe Colin Deeny Julia Kennedy Padraig Moran John Walsh Tim Delaney Carol Keogh Mike Morris Orla Walsh Dairine Dempsey Steve Kerrigan Annalisa Mullan Zephyr Dominic Dowling Niamh Kilcullen Philip Murphy

Audrey Dunne Ciara Kirke Niamh O’Boyle

Typeset and published in Ireland by Irish Pharmacy Journal, 18 Shrewsbury Road, Ballsbridge, Dublin 4